Location History:
- Montreal, CA (2001 - 2002)
- Devizes, GB (2003)
- Salisbury, GB (2001 - 2004)
Company Filing History:
Years Active: 2001-2004
Title: The Innovative Contributions of David Hugh Jones
Introduction
David Hugh Jones is a notable inventor based in Salisbury, GB. He has made significant contributions to the field of biotechnology, particularly in the development of methods for vaccination and gene therapy. With a total of 5 patents to his name, Jones continues to push the boundaries of scientific innovation.
Latest Patents
Among his latest patents is a groundbreaking method of making microencapsulated DNA for vaccination and gene therapy. This method describes a process in which a microparticle containing DNA coding for a polypeptide is created using a solvent extraction method at elevated temperatures. The oral administration of this microparticle leads to its expression, which is crucial for stimulating antibody formation in recipients. Additionally, the DNA coding for a non-immunogenic polypeptide is intended for gene therapy applications. Importantly, the DNA is incorporated into the microparticle without any destruction of its function. Another significant patent focuses on microencapsulated DNA for vaccination and gene therapy, emphasizing the same innovative approach to oral administration and expression.
Career Highlights
David Hugh Jones is currently associated with the Microbiological Research Authority, where he applies his expertise in biotechnology to advance research and development. His work has been instrumental in creating new methodologies that enhance the efficacy of vaccines and gene therapies.
Collaborations
Throughout his career, Jones has collaborated with esteemed colleagues such as Graham Henry Farrar and James Christopher Stephen Clegg. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
David Hugh Jones exemplifies the spirit of innovation in the field of biotechnology. His contributions, particularly in the area of microencapsulated DNA for vaccination and gene therapy, highlight his commitment to advancing medical science. His work continues to inspire future developments in the industry.